SAB Biotherapeutics, Inc.
SABS
$1.79
$0.03992.28%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -63.30% | 1,153.37% | 380.11% | 237.34% | 275.93% |
| Total Receivables | -- | -- | -38.23% | -74.68% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 27.16% | 190.42% | 133.92% | 123.44% | 56.68% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -59.61% | 940.29% | 339.48% | 212.34% | 166.58% |
|
|
|||||
| Total Current Assets | -59.61% | 940.29% | 339.48% | 212.34% | 166.58% |
| Net Property, Plant & Equipment | -19.30% | -16.47% | -16.20% | -16.82% | -12.90% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 37.66% | 38.58% | 20.21% | 27.65% | -25.12% |
| Total Assets | -47.35% | 89.85% | 74.63% | 67.26% | 64.90% |
|
|
|||||
| Total Accounts Payable | 79.16% | 19.74% | -16.56% | -14.19% | -74.29% |
| Total Accrued Expenses | -18.22% | 29.80% | -14.73% | -36.79% | -31.94% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -56.19% | -56.27% | 54.38% | 38.13% | 32.70% |
| Total Finance Division Other Current Liabilities | -- | -92.95% | -96.04% | -87.15% | 1,441.26% |
| Total Other Current Liabilities | -- | -92.95% | -96.04% | -87.15% | 1,441.26% |
| Total Current Liabilities | -26.21% | -4.29% | -31.41% | -39.23% | -27.88% |
|
|
|||||
| Total Current Liabilities | -26.21% | -4.29% | -31.41% | -39.23% | -27.88% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -4.86% | 15.73% | 15.47% | 3.00% | 1.59% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -45.74% | 878.88% | 586.19% | 2,546.24% | 3,569.12% |
| Total Liabilities | -31.59% | 29.16% | 0.29% | 1.53% | 34.24% |
|
|
|||||
| Common Stock & APIC | 1.92% | 76.33% | 76.43% | 80.27% | 81.01% |
| Retained Earnings | -37.87% | -67.80% | -64.92% | -72.19% | -88.14% |
| Treasury Stock & Other | -2.95% | 0.94% | -0.57% | -1.15% | 0.48% |
| Total Common Equity | -54.68% | 141.89% | 133.91% | 116.46% | 84.49% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -54.68% | 141.89% | 133.91% | 116.46% | 84.49% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -54.68% | 141.89% | 133.91% | 116.46% | 84.49% |
|
|
|||||